Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 995

1.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
2.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
3.

Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.

Toh R, Ishida T, Nishimura K, Nonaka H, Inoue Y, Kitagawa Y, Suematsu M, Miki T, Emoto N, Hirata K.

Hypertens Res. 2012 Nov;35(11):1080-6. doi: 10.1038/hr.2012.110. Epub 2012 Jul 12.

PMID:
22786569
4.
5.

The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications.

Greathouse MK, Weir MR.

Postgrad Med. 2012 Mar;124(2):40-52. doi: 10.3810/pgm.2012.03.2535. Review.

PMID:
22437214
6.
7.

Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.

Kim KS, Fan WH, Kim YD, Zhu W, Ngau YY, Tong P, Kim BS, Santos M, Lin WH, Buranakitjaroen P, Massaad R, Smith RD; Asia HEAALTH Study Investigators.

Hypertens Res. 2009 Jun;32(6):520-6. doi: 10.1038/hr.2009.42. Epub 2009 Apr 24.

PMID:
19390542
8.

Long-term antihypertensive efficacy of losartan/hydrochlorothiazide combination therapy on home blood pressure control.

Miyagawa S, Yamada H, Matsubara H.

Clin Exp Hypertens. 2012;34(6):439-46. doi: 10.3109/10641963.2012.665732. Epub 2012 Apr 3.

PMID:
22471874
9.

Current status of antihypertensive prescription and associated blood pressure control in Japan.

Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.

Hypertens Res. 2006 Mar;29(3):143-51.

PMID:
16755149
10.
11.

Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.

Neutel JM.

Curr Med Res Opin. 2008 Aug;24(8):2389-401. doi: 10.1185/03007990802262457. Epub 2008 Jul 9. Review.

PMID:
18616863
13.
15.

[Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].

Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):218-23. doi: 10.1016/j.ancard.2012.05.002. Epub 2012 May 23. French.

PMID:
22695025
16.

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.

Vasc Health Risk Manag. 2011;7:701-8. doi: 10.2147/VHRM.S25743. Epub 2011 Nov 24.

17.

Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.

Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ; INVEST Investigators.

Am J Cardiovasc Drugs. 2007;7 Suppl 1:25-9.

PMID:
19845074
18.

The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

Fox JC, Leight K, Sutradhar SC, Demopoulos LA, Gleim GW, Lewin AJ, Bakris GL.

J Clin Hypertens (Greenwich). 2004 Aug;6(8):437-42; quiz 443-4.

20.

Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.

Suzuki H, Shimada Y, Fujiwara K.

Ther Adv Cardiovasc Dis. 2012 Dec;6(6):237-44. doi: 10.1177/1753944712464285. Epub 2012 Nov 5.

PMID:
23129531

Supplemental Content

Support Center